Differences in Mitochondrial DNA Among Jewish Populations and Type 2 Diabetes Complications
Author Information
Author(s): Feder Jeanette, Blech Ilana, Ovadia Ofer, Amar Shirly, Wainstein Julio, Raz Itamar, Dadon Sarah, Arking Dan E, Glaser Benjamin, Mishmar Dan
Primary Institution: Ben-Gurion University of the Negev
Hypothesis
Do differences in mitochondrial DNA haplogroups among Jewish populations affect susceptibility to complications from type 2 diabetes mellitus (T2DM)?
Conclusion
The study found that specific mitochondrial DNA haplogroups are associated with varying susceptibility to T2DM complications among different Jewish populations.
Supporting Evidence
- Significant differences in mtDNA haplogroup distribution were found among the three Jewish populations.
- Haplogroup N1b1 was associated with a protective effect against T2DM complications in Ashkenazi Jews.
- Haplogroup J1 was linked to increased risk of nephropathy and retinopathy in Ashkenazi Jews.
- Haplogroup HV* was associated with higher risk of nephropathy and cardiovascular disease in North African Jews.
Takeaway
Different groups of Jewish people have unique types of mitochondrial DNA, which can change how likely they are to have problems from diabetes.
Methodology
The study analyzed mitochondrial DNA genetic variability in Ashkenazi, Sephardic, and North African Jewish populations and assessed associations with T2DM complications.
Potential Biases
Potential bias due to population stratification and the specific genetic backgrounds of the studied groups.
Limitations
The findings may not apply to the general population due to the specific nature of the studied Jewish populations.
Participant Demographics
762 Ashkenazi Jews, 191 Sephardic Jews, and 226 North African Jews.
Statistical Information
P-Value
p = 0.006
Confidence Interval
0.15–0.74
Statistical Significance
p < 0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website